Redmile Group, LLC Replimune Group, Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q3 2024

A detailed history of Redmile Group, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 4,781,183 shares of REPL stock, worth $59.8 Million. This represents 3.43% of its overall portfolio holdings.

Number of Shares

4,781,183

Previous 5,562,096 14.04%

Holding current value

$59.8 Million

Previous $50.1 Million 4.68%

% of portfolio

3.43%

Previous 3.26%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $6.32 Million - $8.77 Million	-780,913 Reduced 14.04%	4,781,183 $52.4 Million
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $9.18 Million - $17.3 Million	1,832,113 Added 49.12%	5,562,096 $50.1 Million
Q1 2024 May 15, 2024	SELL	$6.87 - $9.31 $929,339 - $1.26 Million	-135,275 Reduced 3.5%	3,729,983 $30.5 Million
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $3.75 Million - $8.98 Million	-555,275 Reduced 12.56%	3,865,258 $32.6 Million
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $9.52 Million - $14.7 Million	608,545 Added 15.96%	4,420,533 $103 Million
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $17.8 Million - $29.7 Million	-1,019,721 Reduced 21.1%	3,811,988 $67.3 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $20.3 Million - $33.1 Million	1,186,400 Added 32.55%	4,831,709 $131 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $612,759 - $919,139	-46,003 Reduced 1.25%	3,645,309 $63.7 Million
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $2.67 Million - $5.21 Million	-175,200 Reduced 4.53%	3,691,312 $62.7 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $5.38 Million - $7.25 Million	-211,600 Reduced 5.19%	3,866,512 $105 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $3.29 Million - $4.48 Million	-113,400 Reduced 2.71%	4,078,112 $121 Million
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $2.09 Million - $2.89 Million	73,300 Added 1.78%	4,191,512 $161 Million
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $3.77 Million - $5.69 Million	124,813 Added 3.13%	4,118,212 $126 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $15.6 Million - $34.9 Million	662,400 Added 19.89%	3,993,399 $152 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $4.28 Million - $6.12 Million	226,806 Added 7.31%	3,330,999 $76.7 Million
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $1.21 Million - $3.21 Million	123,700 Added 4.15%	3,104,193 $77.1 Million
Q1 2020 May 15, 2020	BUY	$8.9 - $19.08 $1.91 Million - $4.08 Million	214,086 Added 7.74%	2,980,493 $29.7 Million
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $6.42 Million - $9.52 Million	552,990 Added 24.98%	2,766,407 $39.7 Million
Q3 2019 Nov 14, 2019	BUY	$10.01 - $16.87 $164,304 - $276,904	16,414 Added 0.75%	2,213,417 $30.8 Million
Q2 2019 Aug 14, 2019	SELL	$12.51 - $17.28 $193,317 - $267,027	-15,453 Reduced 0.7%	2,197,003 $32.2 Million
Q1 2019 May 15, 2019	BUY	$10.26 - $16.24 $241,099 - $381,623	23,499 Added 1.07%	2,212,456 $33.7 Million
Q4 2018 Feb 14, 2019	SELL	$9.97 - $15.57 $39,880 - $62,280	-4,000 Reduced 0.18%	2,188,957 $21.9 Million
Q3 2018 Nov 14, 2018	BUY	$14.99 - $22.14 $32.9 Million - $48.6 Million	2,192,957 New	2,192,957 $35.3 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $616M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Replimune Group, Inc. Transaction History